Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.22 USD | -0.07% |
|
+2.18% | -0.04% |
| Capitalization | 49.5B 42.56B 38.62B 37.04B 67.64B 4,563B 70.08B 454B 182B 2,176B 186B 182B 7,772B | P/E ratio 2026 * |
29.6x | P/E ratio 2027 * | 26.9x |
|---|---|---|---|---|---|
| Enterprise value | 44.95B 38.65B 35.07B 33.64B 61.43B 4,144B 63.64B 412B 165B 1,976B 169B 165B 7,058B | EV / Sales 2026 * |
6.74x | EV / Sales 2027 * | 5.92x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.07% | ||
| 1 week | +2.18% | ||
| Current month | -1.45% | ||
| 1 month | +6.83% | ||
| 3 months | -0.65% | ||
| 6 months | +5.26% | ||
| Current year | -0.04% |
| 1 week | 83.76 |  | 87.32 |
| 1 month | 74.66 | | 87.32 |
| Current year | 74.66 | | 87.32 |
| 1 year | 65.94 | | 87.89 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 59 | 01/01/2014 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 65 | 05/07/2016 |
| Chairman | 69 | 07/05/2024 | |
Steven Loranger
BRD | Director/Board Member | 74 | 16/03/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.74% | 2.46% | 54 M€ | |
| -0.85% | 2.34% | 26 M€ | |
| -1.38% | 1.17% | 25 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | +2.18% | +19.39% | +4.03% | 49.5B | |
| +0.90% | -0.19% | -0.75% | -8.36% | 190B | |
| +0.76% | -0.99% | -10.18% | +113.39% | 178B | |
| +0.35% | -2.29% | -0.57% | -19.12% | 145B | |
| -2.22% | -1.73% | -30.31% | +51.00% | 107B | |
| -1.94% | -4.32% | -23.44% | -19.91% | 53.73B | |
| +0.30% | +2.58% | +11.91% | +17.85% | 37.74B | |
| +1.14% | -5.96% | -6.27% | +3.47% | 36.01B | |
| +1.26% | -3.35% | -2.05% | -16.25% | 34.06B | |
| -2.58% | -6.00% | -28.56% | -43.87% | 30.79B | |
| Average | -0.30% | -1.65% | -7.08% | +8.22% | 86.22B | |
| Weighted average by Cap. | +0.00% | -1.25% | -7.32% | +22.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67B 5.73B 5.2B 4.99B 9.11B 615B 9.44B 61.13B 24.48B 293B 25.03B 24.49B 1,047B | 7.33B 6.3B 5.72B 5.48B 10.01B 675B 10.37B 67.15B 26.89B 322B 27.5B 26.91B 1,150B |
| Net income | 1.67B 1.44B 1.31B 1.25B 2.29B 154B 2.37B 15.34B 6.14B 73.59B 6.28B 6.15B 263B | 1.82B 1.57B 1.42B 1.36B 2.49B 168B 2.58B 16.72B 6.69B 80.17B 6.85B 6.7B 286B |
| Net Debt | -4.55B -3.91B -3.55B -3.4B -6.22B -419B -6.44B -41.69B -16.69B -200B -17.07B -16.71B -714B | -6.1B -5.25B -4.76B -4.57B -8.34B -563B -8.64B -55.95B -22.4B -268B -22.91B -22.42B -958B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/03/26 | 85.22 $ | -0.07% | 4,439,290 |
| 03/03/26 | 85.28 $ | -2.18% | 5,594,225 |
| 02/03/26 | 87.18 $ | +0.82% | 3,749,413 |
| 27/02/26 | 86.47 $ | +0.66% | 6,172,765 |
| 26/02/26 | 85.90 $ | +3.00% | 3,707,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition